Remove 2014 Remove Hospitals Remove Pharmaceutical Companies
article thumbnail

The 20 Key Moments in the 340B Program's 30-Year History

Omnicell

Interestingly, the 340B law was actually included in a veterans healthcare bill (the Veterans Health Care Act) that also established a separate drug pricing program for veterans hospitals. It also raised the DSH payment cap for some rural and small urban hospitals to 12%. 2006: Congress passed, and President George W.

article thumbnail

Increasing patient engagement with UK clinical trials

pharmaphorum

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. In 2014 Keith was fortunate to become a full-time salaried patient research ambassador at Liverpool Heart and Chest Hospital Trust.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Abiogen acquires EffRx to fortify bone disease portfolio

Pharmaceutical Technology

The Italian pharmaceutical company Abiogen Pharma completed an acquisition of a 97.09% stake in the Swiss orphan conditions-focused EffRx Pharmaceuticals on May 29. Altamedics specialises in pharmaceutical distribution in hospital settings.

article thumbnail

Country focus: China & APAC’s growing medical needs bring opportunities and challenges

pharmaphorum

At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home. All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. About the author. He can be contacted on LinkedIn.

article thumbnail

One world, one health: The interconnected web of antimicrobial resistance

pharmaphorum

The same resistant infection can have drastically different consequences in humans and animals, depending on whether it is acquired in hospital or outside of it, in a high-income country or a low-income one.”.

article thumbnail

Securing every dose with an edible security technology for safe medicines

European Pharmaceutical Review

Second, pharmaceutical companies can implement serialisation of individual medicines, potentially tracking and tracing medicines to ensure brand protection. Third, hospital pharmacies can have more efficient management of drug procurement, distribution and dispensing to hospital inpatients and outpatients.

Dosage 98
article thumbnail

Farxiga for heart failure: How it works, effectiveness & more

The Checkup by Singlecare

Farxiga is an oral prescription drug containing the active ingredient dapagliflozin and made by the pharmaceutical company AstraZeneca. It is classified as a sodium-glucose cotransporter 2 (SGLT2) inhibitor. This new approval meant that more people with heart failure could take Farxiga regardless of LVEF status.